Search / Trial NCT06617039

The Impact of Low-Dose Esketamine Combined With Ciprofol on the Quality of Early Postoperative Recovery Among Elderly Patients Undergoing Painless Gastroscopy

Launched by SUBEI PEOPLE'S HOSPITAL OF JIANGSU PROVINCE · Sep 25, 2024

Trial Information

Current as of December 22, 2024

Not yet recruiting

Keywords

ClinConnect Summary

No description provided

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • 1. Scheduled painless gastroscopy examination and treatment
  • 2. Age 60-75 years old
  • 3. ASA grade Ⅰ-Ⅱ
  • 4. The respiratory tract is unobstructed and there is no difficult airway
  • 5. No history of allergy to etomidate and cyclopropofol
  • 6. Participants with normal heart, liver, lung, and kidney functions
  • 7. Able to complete the QoR-15, MMSE, and HADS scale assessments
  • 8. lnformed consent, voluntary participation in the trial, and signed by the patient informed consent
  • Exclusion Criteria:
  • 1. Participants with concurrent dysfunction of major organs.
  • 2. Participants with a history of mental illness and abuse of sedative drugs
  • 3. Participants with allergies or contraindications to the study drugs
  • 4. Participants with severe visual, auditory, or speech communication impairments
  • 5. Participants with acute gastrointestinal inflammation or obstruction
  • 6. History of uncontrolled diabetes, hypertension, and hypotension
  • 7. Participants with malignant tumors, severe hyperkalemia, bronchial asthma, or excessive obesity (BMI \> 30kg/m2)
  • 8. Participants with aneurysmal vascular diseases of the thoracic and abdominal aorta, intracranial and peripheral arterial vessels.
  • 9. Unable to cooperate with the QoR-15, MMSE, and HADS scale assessments

About Subei People's Hospital Of Jiangsu Province

Subei People's Hospital of Jiangsu Province is a leading healthcare institution dedicated to advancing medical research and improving patient care through innovative clinical trials. With a focus on enhancing therapeutic outcomes, the hospital collaborates with multidisciplinary teams of healthcare professionals and researchers to conduct rigorous studies across various medical fields. Committed to ethical standards and patient safety, Subei People's Hospital plays a pivotal role in translating scientific discoveries into practical treatments, contributing significantly to the advancement of medical knowledge and the enhancement of healthcare delivery in the region.

Locations

Yangzhou, Jiangsu, China

People applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Discussion 0